We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.
- Authors
Boland, E A; Grey, M; Oesterle, A; Fredrickson, L; Tamborlane, W V
- Abstract
Recommendations from the Diabetes Control and Complications Trial (DCCT) indicate that adolescents with type 1 diabetes should be treated with intensive therapy involving multiple daily injections (MDI) of insulin or insulin pump therapy (continuous subcutaneous insulin infusion [CSII] to help obtain better metabolic control and prevent later complications. Interest has thus focused on insulin pump therapy to help adolescents meet this challenge. The purpose of this study was to examine responses to CSII and MDI in a large group of adolescents with established type 1 diabetes during a 12-month period and to determine whether either treatment regimen more favorably affected clinical and psychosocial outcomes.
- Publication
Diabetes care, 1999, Vol 22, Issue 11, p1779
- ISSN
0149-5992
- Publication type
Journal Article
- DOI
10.2337/diacare.22.11.1779